Human rhinovirus 3 at 3.0 Å resolution

Structure

Volumn 4, Issue 10, 1996, Pages 1205-1220

  Zhao, Rui ^a   Pevear, Daniel C ^b   Kremer, Marcia J ^a   Giranda, Vincent L ^c   Kofron, Jennifer A ^d   Kuhn, Richard J ^a   Rossmann, Michael G ^a  

^a PURDUE UNIVERSITY   (United States)

^b ViroPharma Inc   (United States)

^c ABBOTT LABORATORIES   (United States)

^d NONE   (United States)

Author keywords

antigenicity; antiviral compounds; pocket factor; rhinoviruses; stability; structure

Indexed keywords

HUMAN RHINOVIRUS 3; HUMAN RHINOVIRUS SP.; MIRIDAE; PICORNAVIRIDAE; POLIOVIRUS; RHINOVIRUS;

EID: 0030587776     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(96)00128-1     Document Type: Article

References (69)

1. Abraham, G. & Colonno, R.J. (1984). Many rhinovirus serotypes share the same cellular receptor. J. Virol. 51, 340-345.
2. Greve, J.M., et al., & McClelland, A. (1989). The major human rhinovirus receptor is ICAM-1. Cell 56, 839-847.
3. Staunton, D.E., Merluzzi, V.J., Rothlein, R., Barton, R., Marling, S.D. & Springer, T.A. (1989). A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56, 849-853.
4. Uncapher, C.R., DeWitt, C.M. & Colonno, R.J. (1991). The major and minor group receptor families contain all but one human rhinovirus serotype. Virology 180, 814-817.
5. Hofer, F., et al., & Blaas, D. (1994). Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. USA 91, 1839-1842.
6. Rossmann, M.G., et al., & Vriend, G. (1985). Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317, 145-153.
7. Oliveira, M.A., et al., & Rossmann, M.G. (1993). The structure of human rhinovirus 16. Structure 1, 51-68.
8. Kim, S., et al., & McKinlay, M.A. (1989). The crystal structure of human rhinovirus serotype 1A (HRV1 A). J. Mol. Biol. 210, 91-111.
9. Rossmann, M.G. & Palmenberg, A.C. (1988). Conservation of the putative receptor attachment site in picornaviruses. Virology 164, 373-382.
10. Chapman, M.S. & Rossmann, M.G. (1993). Comparison of surface properties of picornaviruses: strategies for hiding the receptor site from immune surveillance. Virology 195, 745-756.
11. Rossmann, M.G. (1994). Viral cell recognition and entry. Protein. Sci. 3, 1712-1725.
12. Colonno, R.J., Condra, J.H., Mizutani, S., Callahan, P.L., Davies, M.E. & Murcko, M.A. (1988). Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc. Natl. Acad. Sci. USA 85, 5449-5453.
13. Olson, N.H., et al., & Rossmann, M.G. (1993). Structure of a human rhinovirus complexed with its receptor molecule. Proc. Natl. Acad. Sci. USA 90, 507-511.
14. Sherry, B., Mosser, A.G., Colonno, R.J. & Rueckert, R.R. (1986). Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J. Virol. 57, 246-257.
15. Smith, T.J., et al., & Baker, T.S. (1993). Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J. Virol. 67, 1148-1158.
16. Smith, T.J., et al., & Otto, M.J. (1986). The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233, 1286-1293.
17. Badger, J., et al., & Heinz, B.A. (1988). Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc. Natl. Acad. Sci. USA 85, 3304-3308.
18. Kim, K.H., et al., & Pevear, D.C. (1993). A comparison of the antirhinoviral drug binding pocket in HRV14 and HRV1A. J. Mol. Biol. 230, 206-225.
19. Pevear, D.C., et al., & Dutko, F.J. (1989). Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J. Virol. 63, 2002-2007.
20. Andries, K., et al., & Janssen, P.A.J. (1990). Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J. Virol. 64, 1117-1123.
21. Hogle, J.M., Chow, M. & Filman, D.J. (1985). Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229, 1358-1365.
22. Filman, D.J., Syed, R., Chow, M., Macadam, A.J., Minor, P.D. & Hogle, J.M. (1989). Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8, 1567-1579.
23. Yeates, T.O., et al., & Hogle, J.M. (1991). Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera. EMBO J. 10, 2331-2341.
24. Smyth, M., Tate, J., Hoey, E., Lyons, C., Martin, S. & Stuart, D. (1995). Implications for viral uncoating from the structure of bovine enterovirus. Nat. Struct. Biol. 2, 224-231.
25. Muckelbauer, U.K., et al., & Rossmann, M.G. (1995). The structure of coxsackievirus B3 at 3.5 A resolution. Structure 3, 653-667.
26. Gruenberger, M., Pevear, D., Diana, G.D., Kuechler, E. & Blaas, D. (1991). Stabilization of human rhinovirus serotype 2 against pH-induced conformational change by antiviral compounds. J. Gen. Virol. 72, 431-433.
27. Fox, M.P., Otto, M.J. & McKinlay, M.A. (1986). The prevention of rhinovirus and poliovirus uncoating by WIN 51711: a new antiviral drug. Antimicrob. Agents Chemother. 30, 110-116.
28. Heinz, B.A., et al., & Smith, T.J. (1989). Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 63, 2476-2485.
29. Bibler-Muckelbauer, J.K., et al., & McKinlay, M.A. (1994). Human rhinovirus 14 complexed with fragments of active antiviral compounds. Virology 202, 360-369.
30. Morton, A., Baase, W.A. & Matthews, B.W. (1995). Energetic origins of specificity of ligand binding in an interior nonpolar cavity of T4 lysozyme. Biochemistry 34, 8564-8575.
31. Eriksson, A.E., Baase, WA., Wozniak, J.A. & Matthews, B.A. (1992). A cavity-containing mutant of T4 lysozyme is stabilized by buried benzene. Nature 355, 371-373.
32. Eriksson, A.E., et al., & Matthews, B.W. (1992). Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect. Science 255, 178-183.
33. DeSana, J. & Mandell, B. (1977). Studies on the in vitro uncoating of poliovirus. II. Characterization of the membrane-modified particle. Virology 78, 554-566.
34. Lonberg-Holm, K. & Korant, B.D. (1972). Early interaction of rhinoviruses with host cells. J. Virol. 9, 29-40.
35. Hoover-Litty, H. & Greve, J.M. (1993). Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion. J. Virol. 67, 390-397.
36. Korant, B.D., Lonberg-Holm, K., Yin, F.H. & Noble-Harvey, J. (1975). Fractionation of biologically active and inactive populations of human rhinovirus type 2. Virology 63, 384-394.
37. Fricks, C.E. & Hogle, J.M. (1990). Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J. Virol. 64, 1934-1945.
38. Jaeger, E.P., Pevear, D.C., Felock, P.J., Russo, G.R. & Treasurywala, A.M. (1995). Genetic algorithm based method to design a primary screen for antirhinovirus agents. In Computer-Aided Molecular Design: Applications in Agrochemicals, Materials, and Pharmaceuticals. (Reynolds, C.H., Holloway, M.X. & Cox, H.K., eds), pp. 139-155, American Chemical Society, Washington D.C., USA.
39. Murray, M.G., Bradley, J., Yang, X.-F., Wimmer, E., Moss, E.G. & Racaniello, V.R. (1988). Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science 241, 213-215.
40. Murray, M.G., Kuhn, R.J., Arita, M., Kawamura, N., Nomoto, A. & Wimmer, E. (1988). Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc. Natl. Acad. Sci. USA 85, 3203-3207.
41. Burke, K.L., Dunn, G., Ferguson, M., Minor, P.D. & Almond, J.W. (1988). Antigen chimeras of poliovirus as potential new vaccines. Nature 332, 81-82.
42. Murdin, A.D. & Wimmer, E. (1989). Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralizing antigenic site II. J. Virol. 63, 5251-5257.
43. Evans, D.J., et al., & Almond, J.W. (1989). An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385-388.
44. Jenkins, O., et al., & Almond, J.W. (1990). An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16. J. Virol. 64, 1201-1206.
45. Ansardi, D.C., Porter, D.C. & Morrow, C.D. (1992). Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J. Virol. 66, 4556-4563.
46. Chow, M., Newman, J.F.E., Filman, D., Hogle, J.M., Rowlands, D.J. & Brown, F. (1987). Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature 327, 482-486.
47. Lee, W.M., Monroe, S.S. & Rueckert, R.R. (1993). Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J. Virol. 67, 2110-2122.
48. Zhao, R., Hadfield, A.T., Kremer, M.J. & Rossmann, M.G. (1996). Cations in human rhinoviruses. Virology, in press.
49. Arnold, E. & Rossmann, M.G. (1990). Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 Å. J. Mol. Biol. 211, 763-801.
50. Ohlin, A., et al., & Greve, J.M. (1994). Spectrum of activity of soluble intercellular adhesion molecule-1 against rhinovirus reference strains and field isolates. Antimicrob. Agents Chemother. 38, 1413-1415.
51. Hiremath, C.N., Grant, RA., Filman, D.J. & Hogle, J.M. (1995). Binding of the antiviral drug WIN51711 to the Sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14. Acta Crystallogr. D 51, 473-489.
52. Palmenberg, A.C. (1989). Sequence alignments of picornaviral capsid proteins. In Molecular Aspects of Picornavirus Infection and Detection. (Semler, B.L. & Ehrenfeld, E., eds), pp. 211-241 , American Society for Microbiology, Washington D.C., USA.
53. Horsnell, C., Gama, R.E., Hughes, P.J. & Stanway, G. (1995). Molecular relationships between 21 human rhinovirus serotypes. J. Gen. Virol. 76, 2549-2555.
54. Medappa, K.C., McLean, C. & Rueckert, R.R. (1971). On the structure of rhinovirus 1A. Virology 44, 259-270.
55. Sanger, F., Nicklin, S. & Coulson, A.R. (1977). DNA sequencing with chain-termination inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
56. Kim, S. (1989). Auto-indexing oscillation photographs. J. Appl. Crystallogr. 22, 53-60.
57. Rossmann, M.G. (1979). Processing oscillation diffraction data for very large unit cells with an automatic convolution technique and profile fitting. J. Appl. Crystallogr. 12, 225-238.
58. Rossmann, M.G., Leslie, A.G.W., Abdel-Meguid, S.S. & Tsukihara, T. (1979). Processing and post-refinement of oscillation camera data. J. Appl. Crystallogr. 12, 570-581.
59. Matthews, B.W. (1968). Solvent content of protein crystals. J. Mol. Biol. 33, 491-497.
60. Rossmann, M.G. & Blow, D.M. (1962). The detection of sub-units within the crystallographic asymmetric unit. Acta Crystallogr. 15, 24-31.
61. Rossmann, M.G., et al., & Choi, H.-K. (1992). Molecular replacement real-space averaging. J. Appl. Crystallogr. 25, 166-180.
62. Muckelbauer, U.K., et al., & Rossmann, M.G. (1995). Structure determination of coxsackievirus B3 to 3.5 A resolution. Acta Crystallogr. D 51, 871-887.
63. Zlotnick, A., McKinney, B.R., Munshi, S., Bibler, J., Rossmann, M.G. & Johnson, J.E. (1993). A monoclinic crystal with R32 pseudo-symmetry: a preliminary report of nodamura virus structure determination. Acta Crystallogr. D 49, 580-587.
64. Llamas-Saiz, A.L., Agbandje-McKenna, M., Wikoff, W.R., Tattersall, P., Bratton, J. & Rossmann, M.G. (1996). Structure determination of minute virus of mice. Acta Crystallogr., in press.
65. Jones, T.A., Zou, J.-Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119.
66. Lea, S., et al., & Mateu, M.G. (1994). The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2, 123-139.
67. Curry, S., et al., & Stuart, D. (1996). Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 4, 135-145.
68. Brünger, A.T. (1993). X-PLOR, Version 3.1 Manual: A System for X-ray Crystallography and NMR. Yale University Press, New Haven, USA.
69. Chapman, M.S. & Rossmann, M.G. (1996). Structural refinement of the DNA-containing capsid of canine parvovirus using RSRef, a resolution-dependent stereochemically restrained real-space refinement method. Acta Crystallogr. D 52, 129-140.